Results 251 to 260 of about 10,595,923 (382)
EndoCompass Project: Research Roadmap for Growth Disorders.
Gevers EF +20 more
europepmc +1 more source
[Application and considerations of recombinant human growth hormone in treating growth disorders in children with chronic kidney disease]. [PDF]
Zhou JH.
europepmc +1 more source
Growth disorders in children and adolescents affected by syndromes or diseases associated with neurodysfunction. [PDF]
Perenc L +3 more
europepmc +1 more source
Fetal growth disorders in twin gestations.
F. Breathnach, F. Malone
semanticscholar +1 more source
Real‐World Investigation of Satralizumab in Patients With Neuromyelitis Optica Spectrum Disease
ABSTRACT Objective Satralizumab, a monoclonal antibody targeting the interleukin‐6 receptor, has demonstrated efficacy in clinical trials for neuromyelitis optica spectrum disorder (NMOSD). However, its real‐world effectiveness and safety compared to conventional immunosuppressive therapies remain uncertain.
Li‐Tsung Lin +2 more
wiley +1 more source
TGFβ Signaling in Growth Control, Cancer, and Heritable Disorders
J. Massagué, S. Blain, R. Lo
semanticscholar +1 more source
ABSTRACT Objective Plasma fibrinogen is essential in thrombosis and fibrinolysis, yet its dynamic changes pre‐ and post‐intravenous thrombolysis (IVT) for predicting brain injury severity and prognosis in acute ischemic stroke (AIS) patients remain unclear.
Wenhai Zhai +28 more
wiley +1 more source
Impact of placenta previa with placenta accreta spectrum disorder on fetal growth [PDF]
Eric Jauniaux +8 more
openalex +1 more source
ABSTRACT Objective This study aims to identify both fluid and neuroimaging biomarkers for CSF1R‐RD that can inform the optimal timing of treatment administration to maximize therapeutic benefit, while also providing sensitive quantitative measurements to monitor disease progression.
Tomasz Chmiela +13 more
wiley +1 more source

